Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration

BACKGROUND: The objective of this study is to describe the use of targeted therapies for the treatment of advanced renal cell carcinoma (RCC) and overall survival (OS) among patients in clinical practice in the Veterans Health Administration (VHA). METHODS: A retrospective cohort of 286 patients fro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Med
Autors principals: Aspinall, Sherrie L., Zhao, Xinhua, Geraci, Mark C., Good, Chester B., Cunningham, Francesca E., Heron, Bernadette B., Becker, Daniel, Lee, Steve, Prasad, Vinay
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Clinical Cancer Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6825975/
https://ncbi.nlm.nih.gov/pubmed/31536684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2531
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars